Organogenesis Holdings Inc. - stock earnings
ORGO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -568000 USD | 99.7 million USD |
2023Q3 | 12.1 million USD | 108.5 million USD |
2023Q2 | 5.3 million USD | 117.3 million USD |
2023Q1 | -3.0 million USD | 107.6 million USD |
2022Q4 | 7.5 million USD | 115.5 million USD |
2022Q3 | 215000 USD | 116.9 million USD |
2022Q2 | 8.7 million USD | 121.4 million USD |
2022Q1 | 87000 USD | 98.1 million USD |
2021Q4 | 51.7 million USD | 128.6 million USD |
2021Q3 | 12.6 million USD | 113.8 million USD |
2021Q2 | 20.7 million USD | 123.2 million USD |
2021Q1 | 9.9 million USD | 102.6 million USD |
2020Q4 | 18.5 million USD | 106.8 million USD |
2020Q3 | 20.9 million USD | 100.8 million USD |
2020Q2 | -5.2 million USD | 69.0 million USD |
2020Q1 | -16.3 million USD | 61.7 million USD |
2019Q4 | -4.4 million USD | 74.6 million USD |
2019Q3 | -10.7 million USD | 64.3 million USD |
2019Q2 | -9.6 million USD | 64.9 million USD |
2019Q1 | -15.7 million USD | 57.1 million USD |
2018Q4 | -9.3 million USD | 63.6 million USD |
2018Q3 | 4.9 million USD | 50.8 million USD |
2018Q2 | 356988 USD | 39.5 million USD |
2018Q1 | -135653 USD | 35.5 million USD |
2017Q4 | -498107 USD | 6.6 million USD |
2017Q3 | -2.1 million USD | 6.3 million USD |
2017Q2 | 380334 USD | ? USD |
2017Q1 | 140863 USD | ? USD |
2016Q4 | -178156 USD | 61084 USD |
2016Q3 | -14492 USD | ? USD |
2016Q2 | -500 USD | ? USD |
2016Q1 | -15550 USD | ? USD |
ORGO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 4.9 million USD | 433.1 million USD |
2022 | 15.5 million USD | 450.9 million USD |
2021 | 94.2 million USD | 468.1 million USD |
2020 | 17.2 million USD | 338.3 million USD |
2019 | -40.5 million USD | 261.0 million USD |
2018 | -64.8 million USD | 193.4 million USD |
2017 | -2.1 million USD | 198.5 million USD |
2016 | -208698 USD | ? USD |
2015 | -25160 USD | 99.0 million USD |
2001 | -2.9 million USD | 1.0 million USD |
ORGO
Price: $2.42
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 33.30
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 317113
Market Capitalization: 380.1 million